| AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
| ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
| BCL10 |
O95999
|
BCL10 immune signaling adaptor
|
|
0.34 |
0.491 |
0.769 |
| BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
| BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
| CARD11 |
Q9BXL7
|
caspase recruitment domain family member 11
|
|
1.00 |
0.582 |
0.615 |
| CCL21 |
O00585
|
C-C motif chemokine ligand 21
|
Signaling
|
3.6E-02 |
0.502 |
0.769 |
| CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
| CCR7 |
P32248
|
C-C motif chemokine receptor 7
|
G-protein coupled receptor
|
5.8E-02 |
0.443 |
0.769 |
| CD28 |
P10747
|
CD28 molecule
|
|
0.36 |
0.436 |
0.885 |
| CD40 |
P25942
|
CD40 molecule
|
|
0.85 |
0.396 |
0.846 |
| CD40LG |
P29965
|
CD40 ligand
|
Signaling
|
0.72 |
0.414 |
0.846 |
| CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
| CD47 |
Q08722
|
CD47 molecule
|
|
0.92 |
0.468 |
0.769 |
| CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
| CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
| CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
| ERBB2 |
P04626
|
erb-b2 receptor tyrosine kinase 2
|
Kinase
|
6.0E-03 |
0.328 |
0.923 |
| FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
| FGFR1 |
P11362
|
fibroblast growth factor receptor 1
|
Kinase
|
1.00 |
0.362 |
0.885 |
| HLA-G |
P17693
|
major histocompatibility complex, class I, G
|
|
1.4E-11 |
0.461 |
0.769 |
| HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
| IL10 |
P22301
|
interleukin 10
|
|
5.9E-03 |
0.281 |
0.923 |
| IL13 |
P35225
|
interleukin 13
|
|
1.4E-02 |
0.386 |
0.846 |
| IL2 |
P60568
|
interleukin 2
|
|
0.48 |
0.336 |
0.885 |